Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Simponi receives approval in Europe for treatment of polyarticular juvenile idiopathic arthritis

July 5, 2016

Pimco 2664 presents compounds for rheumatoid arthritis

July 5, 2016

Ampio announces results from phase III PIVOT clinical trial

July 1, 2016

IL-22 linked to aberrant bone formation in spondyloarthropathies

June 28, 2016

Cytonics' recombinant A2M variants attenuate cartilage degeneration in osteoarthritis models

June 23, 2016

GO-FURTHER data demonstrate golimumab improves hemoglobin levels and anemia

June 22, 2016

Safety and pharmacokinetics of anti-IL-17 MAb assessed in phase I study

June 20, 2016

Changes in absolute lymphocyte counts following up to 8 years of tofacitinib treatment

June 17, 2016

Long-term efficacy and safety of canakinumab

June 16, 2016

twoXAR completes preclinical studies to evaluate rheumatoid arthritis candidates

June 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...